Viewing Study NCT06757335


Ignite Creation Date: 2025-12-24 @ 10:23 PM
Ignite Modification Date: 2025-12-31 @ 4:39 AM
Study NCT ID: NCT06757335
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-03
First Post: 2024-11-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Trial to Evaluate Oral HP568 Tablets in Patients with ER+/HER2 Advanced Breast Cancer
Sponsor: Hinova Pharmaceuticals Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: HP568-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators